网站大量收购独家精品文档,联系QQ:2885784924

国产可降解涂层西罗莫司洗脱支架临床应用的可行性和价格优势.doc

国产可降解涂层西罗莫司洗脱支架临床应用的可行性和价格优势.doc

  1. 1、本文档共6页,可阅读全部内容。
  2. 2、原创力文档(book118)网站文档一经付费(服务费),不意味着购买了该文档的版权,仅供个人/单位学习、研究之用,不得用于商业用途,未经授权,严禁复制、发行、汇编、翻译或者网络传播等,侵权必究。
  3. 3、本站所有内容均由合作方或网友上传,本站不对文档的完整性、权威性及其观点立场正确性做任何保证或承诺!文档内容仅供研究参考,付费前请自行鉴别。如您付费,意味着您自己接受本站规则且自行承担风险,本站不退款、不进行额外附加服务;查看《如何避免下载的几个坑》。如果您已付费下载过本站文档,您可以点击 这里二次下载
  4. 4、如文档侵犯商业秘密、侵犯著作权、侵犯人身权等,请点击“版权申诉”(推荐),也可以打举报电话:400-050-0827(电话支持时间:9:00-18:30)。
查看更多
国产可降解涂层西罗莫司洗脱支架临床应用的可行性和价格优势

国产可降解涂层西罗莫司洗脱支架临床应用的可行性和价格优势 安雅芳(天津市职业病防治院(工人医院)心内科,天津市 300020) 引用本文:安雅芳. 国产可降解涂层西罗莫司洗脱支架临床应用的可行性和价格优势[J].中国组织工程研究,2017,21():946-951. DOI:10.3969/j.issn.2095-4344.2017.06.022 ORCID: 0000-0002-3793-737X(安雅芳) 文章快速阅读: 文题释义: 药物洗脱支架:也可称之为药物释放支架,通过包被于金属支架表面的聚合物携带药物,当支架置入血管内病变部位后,药物自聚合物涂层中通过洗脱方式有控制地释放至心血管壁组织而发挥生物学效应。文中的药物洗脱支架列举了2种,即Tivoli支架和Endeavor支架。其中Tivoli支架为新型的西罗莫司药物洗脱支架,骨架为钴铬合金,支架壁厚度为0.003 1英寸,采用开环设计,金属覆盖率为14.06%,生物可降解涂层包含西罗莫司,聚合物为聚乳酸羟乙酸共聚物,载药量为2.2 μg/mm2,药物涂层可在6个月内完全降解吸收。Endeavor支架涂层为zotarolimusABT-578)药物,支架还涂有磷酸胆碱聚合物有较高的生物相容性,其载药量为10 μg/mm2。 omemade sirolimus-eluting stent with biodegradable coating: feasibility and price advantage An Ya-fang (Department of Cardiology, Tianjin Occupational Diseases Prevention and Therapeutic Hospital (Tianjin Workers’ Hospital), Tianjin 300020, China) Abstract BACKGROUND: The homemade sirolimus-eluting stent with biodegradable coating (Tivoli stent) is cheaper than the imported zotarolimus-eluting stent (Endeavor stent) by half. Tivoli stent has been widely applied in clinic gradually, and its safety and efficacy will be recognized. OBJECTIVE: To explore the feasibility and price advantage of the Tivoli stent versus Endeavor stent. METHODS: 110 patients with coronary heart disease in Tianjin Occupational Diseases Prevention and Therapeutic Hospital (Tianjin Workers’ Hospital) from January 2006 to January 2016 were selected and randomly allotted to two groups, followed by treated with Tivoli or Endeavor stents, respectively. The procedural success rate, the serum level of C-reactive protein before and 1 week after treatment, coronary angiographic results at 8 months after treatment, as well as the incidence of major adverse cardiac and stent thrombosis events during the 270-day follow-up were observed. RESULTS AND CONCLUSION: The successful rate of stent implantation was 100% in both groups. The serum level of C-reactive protein in the patients subjected to Tivoli stent before and 1 week after operation showed no signi

您可能关注的文档

文档评论(0)

jiupshaieuk12 + 关注
实名认证
内容提供者

该用户很懒,什么也没介绍

版权声明书
用户编号:6212135231000003

1亿VIP精品文档

相关文档